Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
…, P Breillat, N Carlier, R Gauzit, C Morbieu… - Science, 2020 - science.org
Coronavirus disease 2019 (COVID-19) is characterized by distinct patterns of disease
progression that suggest diverse host immune responses. We performed an integrated immune …
progression that suggest diverse host immune responses. We performed an integrated immune …
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected …
Background Treatments are urgently needed to prevent respiratory failure and deaths from
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …
coronavirus disease 2019 (COVID-19). Hydroxychloroquine (HCQ) has received worldwide …
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
…, J Danielson, S Burrel, C Morbieu… - Science …, 2023 - science.org
Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …
[HTML][HTML] Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia
…, J Cohen, LBL Nguyen, M Neuville, C Morbieu… - Critical Care, 2016 - Springer
Background Multiplex polymerase chain reaction (mPCR) enables recovery of viruses from
airways of patients with community-acquired pneumonia (CAP), although their clinical impact …
airways of patients with community-acquired pneumonia (CAP), although their clinical impact …
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
…, N Ermak, L Macraigne, C Morbieu… - Annals of the …, 2022 - ard.bmj.com
Objectives The emergence of strains of SARS-CoV-2 exhibiting increase viral fitness and
immune escape potential, such as the Delta variant (B.1.617.2), raises concerns in …
immune escape potential, such as the Delta variant (B.1.617.2), raises concerns in …
[HTML][HTML] Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen: observational comparative study using routine care data
…, C Gourjault, A Lahens, P Legendre, C Morbieu… - Clinical Microbiology …, 2021 - Elsevier
Objective To assess the effectiveness of corticosteroids on outcomes of patients with coronavirus
disease 2019 (COVID-19) pneumonia requiring oxygen without mechanical ventilation. …
disease 2019 (COVID-19) pneumonia requiring oxygen without mechanical ventilation. …
[HTML][HTML] Distal lung inflammation assessed by alveolar concentration of nitric oxide is an individualised biomarker of severe COVID-19 pneumonia
…, C Lorut, M Subileau, F Aubourg, C Morbieu… - Journal of Personalized …, 2022 - mdpi.com
Pulmonary sequelae as assessed by pulmonary function tests (PFTs) are often reported in
patients infected by SARS-CoV-2 during the post-COVID-19 period. Little is known, however, …
patients infected by SARS-CoV-2 during the post-COVID-19 period. Little is known, however, …
[HTML][HTML] Persistent nasal inflammation 5 months after acute anosmia in patients with COVID-19
T Hua-Huy, C Lorut, F Aubourg, C Morbieu… - American Journal of …, 2021 - atsjournals.org
5. Pullamsetti SS, Savai R, Seeger W, Goncharova EA. Translational advances in the field
of pulmonary hypertension: from cancer biology to new pulmonary arterial hypertension …
of pulmonary hypertension: from cancer biology to new pulmonary arterial hypertension …
IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-α blockers
…, B Pigneur, A Régent, C Gay, C Morbieu… - …, 2022 - academic.oup.com
Objective The association of IgA vasculitis (IgAV) and IBD is rarely described, mainly during
anti-TNF-α therapy. We aimed to describe the association of IgAV and IBD. Methods We …
anti-TNF-α therapy. We aimed to describe the association of IgAV and IBD. Methods We …